DB16383InvestigationalProtein Based Therapies
Bexmarilimab is under investigation in clinical trial NCT03733990 (A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients).
- Mechanism
- Curator reviewed
Pharmacologically active on Stabilin-1
- Also known as
- Anti-clever-1 monoclonal antibody FP-1305 · Clevegen
- Code names
- FP-1305
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with Bexmarilimab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account